rQNestin34.5v.2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rQNestin34.5v.2, covering 2026-03-04 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 [Phase 1]